Cargando…

Adherence and clinical outcomes of HIV patients switching to a fixed-dose combination regimen

BACKGROUND: The efficacy of antiretroviral therapy (ART) is monitored using clinical markers such as viral load (VL) and CD4 counts. Adherence to ART has been associated with viral suppression and improved clinical outcomes. OBJECTIVES: To determine the relationship between adherence status with mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kruger-Swanepoel, Geziena E., Lubbe, Martie S., Rakumakoe, Dorcas M., Vorster, Martine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634951/ https://www.ncbi.nlm.nih.gov/pubmed/36338195 http://dx.doi.org/10.4102/sajid.v37i1.464

Ejemplares similares

Spillover adherence effects of fixed-dose combination HIV therapy
por: Kauf, Teresa L, et al.
Publicado: (2012)

Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes
por: Böhm, Anna-Katharina, et al.
Publicado: (2021)

Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review
por: Makhene, Nokuthula L., et al.
Publicado: (2023)

Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
por: Clay, P.G., et al.
Publicado: (2015)

Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
por: Kim, Jae Hui, et al.
Publicado: (2020)

Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care
por: Maskew, Mhairi, et al.
Publicado: (2018)

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
por: Ranzenigo, Martina, et al.
Publicado: (2022)

Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
Publicado: (2022)

Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection
por: Mehta, Rashmi, et al.
Publicado: (2018)

Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
por: Al-Shaer, Mohammad H., et al.
Publicado: (2017)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study
por: Verma, Amol A., et al.
Publicado: (2018)

Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications
por: Jacobs, Karen, et al.
Publicado: (2016)

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)
por: Arasteh, K, et al.
Publicado: (2009)

Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
por: Patel, Bimal V, et al.
Publicado: (2008)

Adherence to antihypertensive fixed-dose combination among Egyptian patients presenting with essential hypertension
por: Hassanein, Mahmoud
Publicado: (2020)

Adherence and Health Care Costs with Single-Pill Fixed-Dose Combinations in Hypertension Management
por: Hilleman, Daniel E.
Publicado: (2014)

Outcome of (131)I therapy in hyperthyroidism using a 550MBq fixed dose regimen
por: Lewis, Anthony, et al.
Publicado: (2013)

Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
por: Wu, Jiun-Ting, et al.
Publicado: (2015)

Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study
por: Aoki, Kazutaka, et al.
Publicado: (2017)

Standards of aminoglycoside therapeutic drug monitoring in a South African private hospital: perspectives and implications
por: du Toit, Mariette, et al.
Publicado: (2019)

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
por: Moosavi, Reza, et al.
Publicado: (2018)

Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in brazil: an ecological study
por: Braga, José Ueleres, et al.
Publicado: (2013)

Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study
por: Chung, Seyong, et al.
Publicado: (2022)

Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis
por: Wei, Qiran, et al.
Publicado: (2023)

Association of outcomes with comprehension, adherence and behavioral characteristics of tuberculosis patients using fixed-dose combination therapy in Contagem, Minas Gerais, Brazil
por: Viegas, Ana Maria, et al.
Publicado: (2017)

The renaissance of fixed dose combinations: Combivir
por: Portsmouth, Simon D, et al.
Publicado: (2007)

Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen
por: Madu, Nneka M, et al.
Publicado: (2022)

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV
por: Munderi, Paula, et al.
Publicado: (2019)

Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis
por: Akazawa, Manabu, et al.
Publicado: (2013)

Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination
por: Fuwa, Masahiro, et al.
Publicado: (2016)

Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations
por: Levi, Miriam, et al.
Publicado: (2016)

Fixed Dose Versus Loose Dose: Analgesic Combinations
por: Pergolizzi, Joseph, et al.
Publicado: (2023)

Switching from concomitant therapy to tafluprost/timolol fixed combination
por: Inoue, Kenji, et al.
Publicado: (2018)

Evaluation of adherence to morning versus evening glaucoma medication dosing regimens
por: Kahook, Malik Y, et al.
Publicado: (2007)

900. Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen (TBR) in Maintaining Virologic Suppression Through 144 Weeks (TANGO Study)
por: Osiyemi, Olayemi, et al.
Publicado: (2021)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro, Jordi, et al.
Publicado: (2016)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Fixed-dose combinations: An essential for rational preparation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7g96mdlbej5k36v2pj3dn03qo3